MedPage Today on MSN
Amikacin eases MAC lung disease in first-line treatment
Randomized trial might expand use from refractory cases ...
About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.
Woman's World on MSN
This COPD medication may reverse fatty liver disease in just four weeks
Like high blood pressure, fatty liver disease has a way of sneaking up on people, often not causing noticeable symptoms until ...
Few situations are more unsettling than not being able to breathe. Whether from a momentary injury that knocks the wind out of you, swimming underwater for too long or recovering after sprinting at ...
Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory ...
By Bhanvi Satija LONDON, May 18 (Reuters) - French drugmaker Sanofi said on Monday a trial showed its rare disease therapy ...
November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...
Treprostinil currently carries indications for improving exercise ability in pulmonary arterial hypertension and pulmonary ...
MedPage Today on MSN
Lung Biopsy Cryoprobe Increases Diagnostic Yield Over Standard Forceps
And randomized trial shows safety is on par ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results